<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05102227</url>
  </required_header>
  <id_info>
    <org_study_id>CROSS LEFT</org_study_id>
    <nct_id>NCT05102227</nct_id>
  </id_info>
  <brief_title>Cardiac ResynchronizatiOn and arrhythmiaS Sensing Via the LEFT Bundle.</brief_title>
  <acronym>CROSS LEFT</acronym>
  <official_title>Cardiac ResynchronizatiOn and arrhythmiaS Sensing Via the LEFT Bundle. The CROSS LEFT Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of ventricular arrhythmias sensing via a left bundle branch area pacing lead.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 25, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Actual">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with successful defibrillation at 35 Joules.</measure>
    <time_frame>24 hours</time_frame>
    <description>After manual induction of ventricular fibrillation, a 35 Joules will be delivered with the implanted defibrillator.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time from ventricular fibrillation induction to defibrillation shock.</measure>
    <time_frame>24 hours</time_frame>
    <description>After manual induction of ventricular fibrillation, the duration of appropriate ventricular sensing will be measured until the 35 Joules shock is delivered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of appropriate and inappropriate arrhythmic episodes.</measure>
    <time_frame>6 months</time_frame>
    <description>The occurrence of appropriately or inappropriately detected episodes with a high ventricular rate ≥170 beats-per-minute will be recorded.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">10</enrollment>
  <condition>Left Bundle Branch Area Pacing</condition>
  <arm_group>
    <arm_group_label>LBBAP</arm_group_label>
    <description>Patients implanted with a dual-chamber DF-1 cardioverter-defibrillator. Ventricular tachy sensing is performed via an IS-1 pacing lead placed in the interventricular septum.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Left bundle branch area pacing</intervention_name>
    <description>A dual-chamber DF-1 defibrillator is implanted. Left bundle branch area pacing is performed for cardiac resynchronization therapy.</description>
    <arm_group_label>LBBAP</arm_group_label>
    <other_name>Cardioverter-defibrillator implantation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients with an indication of a new implantation of a cardiac&#xD;
        resynchronization therapy system.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ischemic or non-ischemic cardiomyopathy&#xD;
&#xD;
          -  Left ventricular ejection fraction ≤35% despite optimal medical therapy&#xD;
&#xD;
          -  Left bundle branch block with QRS ≥130 milliseconds&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previously implanted intra-cardiac material&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHRU de Tours</name>
      <address>
        <city>Tours</city>
        <state>Please Select...</state>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 4, 2021</study_first_submitted>
  <study_first_submitted_qc>October 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Tours</investigator_affiliation>
    <investigator_full_name>Nicolas Clementy, MD, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD may be shared with manuscript reviewers, upon reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

